Drug Profile
WP 401
Alternative Names: 2'-Bromo-4'-epidaunorubicinLatest Information Update: 24 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cytostatic antibiotics
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 24 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 18 Jan 1999 New profile
- 18 Jan 1999 Preclinical development for Cancer in USA (Unknown route)